BARD ASSOCIATES INC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.8%.

Quarter-by-quarter ownership
BARD ASSOCIATES INC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$175,000
-44.4%
335,750
-19.0%
0.02%
-45.7%
Q2 2020$315,000
+288.9%
414,500
+422.0%
0.04%
-41.7%
Q1 2020$81,000
-35.2%
79,400
-1.7%
0.06%
-6.2%
Q4 2019$125,000
-17.8%
80,800
-3.6%
0.06%
-16.9%
Q3 2019$152,000
+5.6%
83,800
-4.6%
0.08%
+6.9%
Q2 2019$144,000
-8.9%
87,884
-0.3%
0.07%
-10.0%
Q1 2019$158,000
-6.5%
88,184
-1.5%
0.08%
-18.4%
Q4 2018$169,000
-89.6%
89,559
-80.3%
0.10%
-34.7%
Q3 2018$1,625,000
+72.0%
455,2950.0%0.15%
+70.5%
Q2 2018$945,000455,2950.09%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders